Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAT2A |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → MAT2A |
| (<<) ELF4 → MAT2A |
| (<<) HSD17B2 → MAT2A |
| (<<) KLF11 → MAT2A |
| (<<) NUDT6 → MAT2A |
| (<<) PKM2 → MAT2A |
| (<<) RBKS → MAT2A |
| (<<) RHOA → MAT2A |
| (<<) RPL35 → MAT2A |
| (<<) SOD1 → MAT2A |
| (<<) ST3GAL6 → MAT2A |
| (<<) TUBA1B → MAT2A |
| (<<) TUBA1C → MAT2A |
| Downstream (Children) |
|---|
| MAT2A → CCNA1 (>>) |
| MAT2A → CDCP1 (>>) |
| MAT2A → CHAF1A (>>) |
| MAT2A → CREB5 (>>) |
| MAT2A → DUSP10 (>>) |
| MAT2A → EFHD2 (>>) |
| MAT2A → EVX1 (>>) |
| MAT2A → INPPL1 (>>) |
| MAT2A → LRCH4 (>>) |
| MAT2A → MST1R (>>) |
| MAT2A → PLCB3 (>>) |
| MAT2A → RPL36 (>>) |
| MAT2A → SH3GLB2 (>>) |
| MAT2A → SLC26A1 (>>) |
| MAT2A → SOX9 (>>) |
| MAT2A → STX1A (>>) |
| MAT2A → SYK (>>) |
